(Q46480713)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18631863%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Immune modulation in corneal transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18631863%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18631863%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Hongmei Fu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18631863%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Daniel F P Larkin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18631863%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18631863%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

published in

Transplantation Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18631863%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18631863%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18631863%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

105-115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18631863%20AND%20SRC:MED&resulttype=core&format=json

How successful is corneal transplantation? A report from the Australian Corneal Graft Register

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Corneal transplantation: the forgotten graft.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Corneal allografts fail to express Ia antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

The immune privilege of corneal grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

The expression of HLA antigens by cells in the human cornea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Factors Predictive of Corneal Graft Survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Immunology and immunomodulation of corneal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: evidence that graft antigens are recognized exclusively via the "indirect pathway"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Corticosteroids in corneal graft rejection. Oral versus single pulse therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Corticosteroid therapy of eye disease. Fifty years later

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Immunosuppressive drugs in immune and inflammatory ocular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Immunosuppression in pediatric solid organ transplantation: opportunities, risks, and management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

The impact of corneal allograft rejection on the long-term outcome of corneal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Conclusions of the corneal transplant follow up study. Collaborating Surgeons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Induction of specific unresponsiveness to cardiac allografts by short-term administration of anti-T cell receptor alpha beta antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Induction of long-term rat renal allograft survival by pretransplant T cell receptor-alpha/beta-targeted therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

alpha/beta-T cell receptor-directed therapy in rat allograft recipients. Long-term survival of cardiac allografts after pretreatment with R73 mAb is associated with upregulation of Th2-type cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Immunomodulation with anti-alphabeta T-cell receptor monoclonal antibodies in combination with cyclosporine A improves regeneration in nerve allografts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Suppression of allograft rejection with anti-alphabeta T cell receptor antibody in rat corneal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Patterns of corneal graft rejection in the rabbit and reversal of rejection with monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Corneal rat-to-mouse xenotransplantation and the effects of anti-CD4 or anti-CD8 treatment on cytokine and nitric oxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

CD8+ T cell-mediated delayed rejection of orthotopic guinea pig cornea grafts in mice deficient in CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

A cell culture model for T lymphocyte clonal anergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

T-cell regulation by CD28 and CTLA-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

CTLA-4 is a second receptor for the B cell activation antigen B7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

CTLA-4 ligation blocks CD28-dependent T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Inhibition of corneal allograft reaction by CTLA4-Ig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Protection of corneal allografts by CTLA4-Ig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Local or short-term systemic costimulatory molecule blockade prolongs rat corneal allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Influence of local and systemic CTLA4Ig gene transfer on corneal allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Effects of CTLA4-Ig gene-modified dendritic cells on the corneal allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Ballistic transfer of minimalistic immunologically defined expression constructs for IL4 and CTLA4 into the corneal epithelium in mice after orthotopic corneal allograft transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

CTLA-4-Ig regulates tryptophan catabolism in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

When ligand becomes receptor--tolerance via B7 signaling on DCs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

T-cell co-stimulation through B7RP-1 and ICOS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Characterization of human inducible costimulator ligand expression and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Differential effects of costimulatory pathway modulation on corneal allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

7 January 2021

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

7 January 2021

The hyper IgM syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

The CD40 pathway in allograft rejection, acceptance, and tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Effect of locally administered anti-CD154 (CD40 ligand) monoclonal antibody on survival of allogeneic corneal transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Mechanisms of immunotherapeutic intervention by anti-CD154 (CD40L) antibody in high-risk corneal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

T-cell costimulatory pathways in allograft rejection and tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Identification and characterization of a new member of the TNF family that induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Roles of tumor necrosis factor-related apoptosis-inducing ligand in corneal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Cytokine and chemokine expression kinetics after corneal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Cytokine mRNA Expression During Experimental Corneal Allograft Rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Effect of interleukin-10 on human anti-porcine xenogeneic cellular response in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Early expression of proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha after corneal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine IL-12-p40 but not IL-4 to donor corneal endothelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

The role of interleukin-1 in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

In Vivo Angiogenic Activity of Interleukins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Effect of cytokine-induced migration of Langerhans cells on corneal allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Topical interleukin 1 receptor antagonist promotes corneal transplant survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Interleukin 10 Treatment Does Not Prolong Experimental Corneal Allograft Survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Murine interleukin 4 transgenic heart allograft survival prolonged with down-regulation of the Th1 cytokine mRNA in grafts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Survival of corneal allografts following adenovirus-mediated gene transfer of interleukin-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Enzymic formation of D-kynurenine from D-tryptophan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Inhibition of T cell proliferation by macrophage tryptophan catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Prevention of allogeneic fetal rejection by tryptophan catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

THE role of indoleamine 2,3-dioxygenase in the anti-tumour activity of human interferon-γin vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Local overexpression of nerve growth factor in rat corneal transplants improves allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Tolerogenic response: allorecognition pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Adenovirus-mediated gene delivery to the corneal endothelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

Langerhans cells of the ocular surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.005